Examiner David E. Gallis

Appears inactive Last observed office action: July 2010 (189 months ago).

Examiner David E. Gallis appears to be very easy relative to their art unit, group, tech center, and USPTO peers. Their lifetime grant ratio is 76.7%, they average 1.51 office actions per granted patent, and their rejection profile leans toward §112, with occasional §101 rejections and elevated §112 usage.

Difficulty vs AU Very Easy

Difficulty vs Group Very Easy

Difficulty vs TC Very Easy

Difficulty vs USPTO Very Easy

Average OA / Grant 1.51

Export

Word PDF

Create account to export.

Examiner Details

Observed Examiner Years: 3 years (2008-2010)
Tech Center: 1600 - Biotechnology and Organic
Group: 1620 - Biomedicinal Chemistry

Metrics

Applications Evaluated: 133
Granted Applications: 102
Non-Granted Applications: 31
Avg OA / Grant: 1.51
Last OA Observed: July 2010 (189 months ago)
Art Units Seen: 1625
Work Groups Seen: 1620 - Biomedicinal Chemistry

Context Comparison

Scope	Examiners	Lifetime Grant Ratio	Avg OA / Grant
This Examiner	1	76.7%	1.51
Art Unit	30	57.0%	1.54
Group	248	48.3%	1.76
Tech Center	1,349	39.5%	2.02
USPTO	16,116	54.8%	1.98

Grant Timeline

Shaded region marks the last two observed years, where grant outcomes may lag due to recency.

Year	Applications	Granted	Grant Rate
No observed data before 2008; examiner may not yet have been active in the available dataset.
2008	47	35	74.5%
2009	68	51	75.0%
2010	18	16	88.9%
No observed data after 2010; examiner may have gone inactive or moved out of examining work.

102 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA #	Office Actions	§ 101 Percentage	§ 102 Percentage	§ 103 Percentage	§ 112 Percentage
1	133	6.0%	12.0%	34.6%	44.4%
2	50	0.0%	12.0%	42.0%	32.0%
3	10	0.0%	20.0%	40.0%	30.0%
4	1	0.0%	0.0%	0.0%	100.0%

§ 101 Yearly Trend

2.4%

2008

6.5%

2009

0.0%

2010

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.